Telix Pharmaceuticals (NASDAQ:TLX) executives highlighted commercial momentum in prostate cancer imaging and outlined multiple clinical programs in oncology during an H.C. Wainwright discussion featuring CEO Chris Behrenbruch and CMO David Cade.
Company overview and 2026 revenue outlook
Behrenbruch
Source link
S&P 500: Pain Is Necessary (Technical Analysis) Source link
This article was written by Follow Calamos Investments is a diversified global investment firm offering innovative investment strategies including U.S. growth equity, global equity, convertible, multi-asset and alternatives. The firm offers strategies through separately managed portfolios, mutual funds, closed-end funds, private funds, an exchange traded fund and UCITS funds. Clients include major corporations, pension funds,…
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a ho Source link
Guts Stock Overview: Latest Trends and Data To Know About Home Stocks Guts Stock Overview: Latest Trends and Data To Know About Source link
All 3 “DrBourse Help For Beginners” forums contain a series of “RANDOM POSTS” on subjects and items that may be of interest to beginners… My intention is to lodge numerous posts to start with, then enter into “CONSTRUCTIVE DISCUSSIONS” that are geared toward assisting with beginner’s education in the various aspects of Share Trading…. These…
This week’s ai stock spotlight is Nvidia ($NVDA) The most valuable company in the world today doesn’t make phones, doesn’t run a social network, and doesn’t sell you toilet paper by drone. No — it’s a company that makes chips. Not the crunchy kind. The kind that power artificial intelligence, video games, self-driving cars, and…